TS
Two Seas Capital LP cut its ABUS stake below 5%
Two Seas Capital LP reported owning 4.1% of Arbutus Biopharma Corp (ABUS) (8,143,994 shares) in a Schedule 13G filed Nov 16, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Nov 16, 2026
- Source
- Schedule 13G